We are the first CRO in southern Sweden to offer Olink®'s novel proteomics technology for sample testing!
Utilizing our extensive immunoassay expertise and adding cutting-edge high-multiplex immunoassay technology to streamline your early drug development process. With fast and reliable results, we support you in making better-informed decisions and progressing toward better treatments for patients.
Today, we are unboxing Olink’s novel Proximity Extension Assay (PEA) technology! This technology allows for the simultaneous measurement of up to 92 proteins in a minimal volume of biological matrices. It is a high-throughput approach that significantly reduces the time and resources needed for biomarker discovery.